166 related articles for article (PubMed ID: 3125973)
1. A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission.
Liberati AM; Ballatori E; Fizzotti M; Schippa M; Cini L; Cinieri S; Proietti MG; Di Marzio R; Senatore M; Grignani F
Cancer Immunol Immunother; 1988; 26(1):87-93. PubMed ID: 3125973
[TBL] [Abstract][Full Text] [Related]
2. Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.
Liberati AM; Brugia M; Edwards BS; Bertoni P; Ballatori E; Puxeddu A; Grignani F
Cancer Immunol Immunother; 1985; 19(2):136-41. PubMed ID: 3872709
[TBL] [Abstract][Full Text] [Related]
3. Immunologic profile in patients with Hodgkin's disease in complete remission.
Liberati AM; Ballatori E; Fizzotti M; Schippa M; Proietti MG; Di Marzio R; Pecci A; Biscetti L; Sbarretti R; Cini L
Cancer; 1987 Jun; 59(11):1906-13. PubMed ID: 3105863
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of interleukin-2 and gamma-interferon production in vitro on cord blood lymphocytes and in vivo on primary cellular immunodeficiency patients with thymic extract (thymostimulin).
Lin CY; Kuo YC; Lin CC; Ou BR
J Clin Immunol; 1988 Mar; 8(2):103-7. PubMed ID: 3131384
[TBL] [Abstract][Full Text] [Related]
5. Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. A report from the Italian Lymphoma Study Group (GISL).
Federico M; Gobbi PG; Moretti G; Avanzini P; Di Renzo N; Cavanna L; Ascari E; Silingardi V
Am J Clin Oncol; 1995 Feb; 18(1):8-14. PubMed ID: 7847265
[TBL] [Abstract][Full Text] [Related]
6. Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cells.
Bergmann L; Mitrou PS; Demmer-Dieckmann M; Ruhmann FT; Weidmann E
Cancer Immunol Immunother; 1987; 25(1):59-64. PubMed ID: 3496158
[TBL] [Abstract][Full Text] [Related]
7. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
Haas GS; Halperin E; Doseretz D; Linggood R; Russell PS; Colvin R; Barrett L; Cosimi AB
J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
[TBL] [Abstract][Full Text] [Related]
8. Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production.
Kosmaczewska A; Frydecka I; Boćko D; Ciszak L; Teodorowska R
Br J Haematol; 2002 Jul; 118(1):202-9. PubMed ID: 12100149
[TBL] [Abstract][Full Text] [Related]
9. T lymphocytes in children with recurrent respiratory infections: effect of the use of thymostimulin on the alterations of T-cell subsets.
De Martino M; Rossi ME; Muccioli AT; Vierucci A
Int J Tissue React; 1984; 6(3):223-8. PubMed ID: 6332795
[TBL] [Abstract][Full Text] [Related]
10. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
Moncada E; Subirá ML; Oleaga A; Goñi F; Sánchez-Ibarrola A; Monreal M; Sevilla M; Goñi MJ; Yoldi A; Terán D
J Autoimmun; 1990 Oct; 3(5):625-38. PubMed ID: 2252531
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of immunomodulating treatment (thymostimulin) in chronic obstructive pulmonary disease.
Banos V; Gómez J; García A; Ruiz J; Alvarez R; Lorenzo M; Canteras M; Valdés M
Respiration; 1997; 64(3):220-3. PubMed ID: 9154674
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery.
Faist E; Markewitz A; Fuchs D; Lang S; Zarius S; Schildberg FW; Wachter H; Reichart B
Ann Surg; 1991 Sep; 214(3):264-73; discussion 274-5. PubMed ID: 1929608
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
14. Thymostimulin prophylaxis of postoperative infections in anergic patients.
Farina EC; Garino M; Balbo G
Can J Surg; 1986 Nov; 29(6):445-6. PubMed ID: 3536050
[TBL] [Abstract][Full Text] [Related]
15. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
Rep MH; Schrijver HM; van Lopik T; Hintzen RQ; Roos MT; Adèr HJ; Polman CH; van Lier RA
J Neuroimmunol; 1999 Apr; 96(1):92-100. PubMed ID: 10227428
[TBL] [Abstract][Full Text] [Related]
16. The in vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin's disease.
Martelli MF; Velardi A; Rambotti P; Cernetti C; Bertotto A; Spinozzi F; Bracaglia AM; Falini B; Davis S
Cancer; 1982 Aug; 50(3):490-7. PubMed ID: 7046903
[TBL] [Abstract][Full Text] [Related]
17. T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1.
Schulof RS; Chorba TL; Cleary PA; Palaszynski SR; Alabaster O; Goldstein AL
Cancer; 1985 Mar; 55(5):974-83. PubMed ID: 3155644
[TBL] [Abstract][Full Text] [Related]
18. The effect of thymic substances on T circulating cells of patients treated for Hodgkin's disease.
Chisesi T; Capnist G; Rancan L; Pellizzari G; Vespignani M
J Biol Regul Homeost Agents; 1988; 2(4):193-8. PubMed ID: 3074627
[TBL] [Abstract][Full Text] [Related]
19. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients.
Velardi A; Spinozzi F; Rambotti P; Tabilio A; Losito A; Zampi I; Cernetti C; Martelli MF; Grignani F; Davis S
J Clin Oncol; 1983 Feb; 1(2):117-25. PubMed ID: 6668495
[TBL] [Abstract][Full Text] [Related]
20. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
Platzer E; Rubin BY; Lu L; Welte K; Broxmeyer HE; Moore MA
J Immunol; 1985 Jan; 134(1):265-71. PubMed ID: 3917276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
